Penumbra, Inc. (NYSE:PEN) Shares Sold by Trillium Asset Management LLC

Trillium Asset Management LLC reduced its holdings in Penumbra, Inc. (NYSE:PEN) by 3.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 37,547 shares of the company’s stock after selling 1,528 shares during the quarter. Trillium Asset Management LLC’s holdings in Penumbra were worth $8,916,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. True Wealth Design LLC acquired a new position in Penumbra during the third quarter worth $26,000. UMB Bank n.a. raised its holdings in Penumbra by 57.4% during the fourth quarter. UMB Bank n.a. now owns 192 shares of the company’s stock worth $46,000 after purchasing an additional 70 shares during the last quarter. Mather Group LLC. raised its holdings in Penumbra by 208.0% during the fourth quarter. Mather Group LLC. now owns 308 shares of the company’s stock worth $73,000 after purchasing an additional 208 shares during the last quarter. Advisors Asset Management Inc. raised its holdings in Penumbra by 11.5% during the third quarter. Advisors Asset Management Inc. now owns 416 shares of the company’s stock worth $81,000 after purchasing an additional 43 shares during the last quarter. Finally, Jones Financial Companies Lllp raised its holdings in Penumbra by 25.0% during the fourth quarter. Jones Financial Companies Lllp now owns 375 shares of the company’s stock worth $89,000 after purchasing an additional 75 shares during the last quarter. 88.88% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages recently issued reports on PEN. Robert W. Baird lifted their price objective on Penumbra from $305.00 to $328.00 and gave the stock an “outperform” rating in a report on Wednesday, February 19th. Truist Financial raised their price target on Penumbra from $285.00 to $325.00 and gave the stock a “buy” rating in a research report on Wednesday, February 19th. Citigroup raised their price target on Penumbra from $220.00 to $245.00 and gave the stock a “neutral” rating in a research report on Wednesday, December 11th. Bank of America assumed coverage on Penumbra in a research report on Friday, March 14th. They set a “buy” rating and a $320.00 price target for the company. Finally, Piper Sandler reissued an “overweight” rating and set a $330.00 price target (up previously from $250.00) on shares of Penumbra in a research report on Wednesday, February 19th. Four equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $294.47.

Insider Activity at Penumbra

In other Penumbra news, EVP Johanna Roberts sold 600 shares of the business’s stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $287.43, for a total transaction of $172,458.00. Following the transaction, the executive vice president now owns 66,539 shares in the company, valued at $19,125,304.77. The trade was a 0.89 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Harpreet Grewal sold 167 shares of the business’s stock in a transaction dated Friday, January 3rd. The stock was sold at an average price of $241.28, for a total value of $40,293.76. Following the transaction, the director now owns 8,530 shares in the company, valued at approximately $2,058,118.40. This represents a 1.92 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 79,918 shares of company stock worth $22,054,293. 5.00% of the stock is owned by insiders.

Penumbra Price Performance

Shares of Penumbra stock opened at $275.40 on Wednesday. Penumbra, Inc. has a twelve month low of $148.00 and a twelve month high of $310.00. The stock has a market capitalization of $10.61 billion, a P/E ratio of 810.01, a PEG ratio of 2.83 and a beta of 0.51. The company has a current ratio of 6.01, a quick ratio of 3.25 and a debt-to-equity ratio of 0.02. The business’s fifty day moving average price is $271.17 and its 200 day moving average price is $238.92.

Penumbra (NYSE:PEN) last issued its earnings results on Tuesday, February 18th. The company reported $0.97 earnings per share for the quarter, beating analysts’ consensus estimates of $0.88 by $0.09. Penumbra had a return on equity of 9.74% and a net margin of 1.17%. The firm had revenue of $315.52 million for the quarter, compared to analysts’ expectations of $311.63 million. As a group, research analysts anticipate that Penumbra, Inc. will post 3.67 earnings per share for the current year.

About Penumbra

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.